MediciNova Inc (MNOV)
1.355
+0.02
(+1.88%)
USD |
NASDAQ |
Apr 24, 16:00
1.34
-0.02
(-1.11%)
After-Hours: 20:00
MediciNova Cash from Financing (TTM)
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2021 | 20.78M |
| September 30, 2021 | 21.10M |
| June 30, 2021 | 25.98M |
| March 31, 2021 | 26.79M |
| December 31, 2020 | 7.106M |
| September 30, 2020 | 10.08M |
| June 30, 2020 | 8.126M |
| March 31, 2020 | 7.105M |
| December 31, 2019 | 10.62M |
| September 30, 2019 | 8.800M |
| June 30, 2019 | 5.640M |
| March 31, 2019 | 7.703M |
| December 31, 2018 | 42.81M |
| September 30, 2018 | 45.80M |
| June 30, 2018 | 49.35M |
| March 31, 2018 | 49.77M |
| December 31, 2017 | 10.80M |
| September 30, 2017 | 6.530M |
| June 30, 2017 | 2.979M |
| March 31, 2017 | 0.7555M |
| December 31, 2016 | 8.666M |
| September 30, 2016 | 8.412M |
| June 30, 2016 | 24.60M |
| March 31, 2016 | 24.90M |
| December 31, 2015 | 17.56M |
| Date | Value |
|---|---|
| September 30, 2015 | 18.35M |
| June 30, 2015 | 2.182M |
| March 31, 2015 | 1.482M |
| December 31, 2014 | 4.162M |
| September 30, 2014 | 3.464M |
| June 30, 2014 | 3.965M |
| March 31, 2014 | 15.05M |
| December 31, 2013 | 13.37M |
| September 30, 2013 | 13.75M |
| June 30, 2013 | 14.14M |
| March 31, 2013 | 3.153M |
| December 31, 2012 | 1.545M |
| September 30, 2012 | 8.400M |
| June 30, 2012 | 7.267M |
| March 31, 2012 | -6.907M |
| December 31, 2011 | 0.1557M |
| September 30, 2011 | -7.075M |
| June 30, 2011 | -8.788M |
| March 31, 2011 | 7.607M |
| December 31, 2010 | -0.9266M |
| September 30, 2010 | -0.9677M |
| June 30, 2010 | 1.108M |
| March 31, 2010 | -1.449M |
| December 31, 2009 | 18.09M |
| September 30, 2009 | 18.06M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
5.640M
Minimum
Jun 2019
26.79M
Maximum
Mar 2021
13.83M
Average
10.08M
Median
Sep 2020
Cash from Financing (TTM) Benchmarks
| NovaBay Pharmaceuticals Inc | 1.91M |
| Palatin Technologies Inc | 5.553M |
| iBio Inc | 10.68M |
| Theriva Biologics Inc | 0.625M |
| Oragenics Inc | 0.2839M |